In the original publication of this abstract, [Singh T, Casabona G, Abu-Elyazeed R, et al. A Report of the Postmarketing Spontaneous Safety Data over 24 Years for GSK’s Measles-Mumps-Rubella (MMR) Vaccine, Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, ofac492.624, https://doi.org/10.1093/ofid/ofac492.624], there were additional GSK locations for members of the byline which were not recorded as affiliations. This has been corrected in the version of the proof currently available online.
. 2023 May 8;10(5):ofad249. doi: 10.1093/ofid/ofad249
Correction to: 571. A Report of the Postmarketing Spontaneous Safety Data over 24 Years for GSK’s Measles-Mumps-Rubella (MMR) Vaccine
Collection date 2023 May.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC10166515 PMID: 37168799
This corrects the article "571. A Report of the Postmarketing Spontaneous Safety Data over 24 Years for GSK’s Measles-Mumps-Rubella (MMR) Vaccine" in volume 9, ofac492.624.